Nikko Asset Management Americas’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-907,930
| Closed | -$9.15M | – | 202 |
|
|
2022
Q4 | $9.15M | Sell |
907,930
-380,928
| -30% | -$3.84M | 0.13% | 87 |
|
|
2022
Q3 | $26.7M | Buy |
1,288,858
+18,293
| +1% | +$380K | 0.34% | 53 |
|
|
2022
Q2 | $29.3M | Buy |
1,270,565
+7,699
| +0.6% | +$177K | 0.36% | 60 |
|
|
2022
Q1 | $46.5M | Buy |
1,262,866
+20,023
| +2% | +$737K | 0.34% | 58 |
|
|
2021
Q4 | $72.2M | Sell |
1,242,843
-3,727
| -0.3% | -$217K | 0.38% | 57 |
|
|
2021
Q3 | $72.3M | Buy |
1,246,570
+221,051
| +22% | +$12.8M | 0.31% | 62 |
|
|
2021
Q2 | $87.3M | Buy |
1,025,519
+463,924
| +83% | +$39.5M | 0.34% | 61 |
|
|
2021
Q1 | $46.3M | Buy |
561,595
+23,931
| +4% | +$1.97M | 0.23% | 83 |
|
|
2020
Q4 | $48.9M | Buy |
537,664
+49,265
| +10% | +$4.48M | 0.28% | 71 |
|
|
2020
Q3 | $19.3M | Sell |
488,399
-38,912
| -7% | -$1.54M | 0.17% | 84 |
|
|
2020
Q2 | $17.1M | Sell |
527,311
-398,698
| -43% | -$12.9M | 0.22% | 68 |
|
|
2020
Q1 | $20.6M | Buy |
926,009
+106,199
| +13% | +$2.36M | 0.38% | 65 |
|
|
2019
Q4 | $16M | Sell |
819,810
-20,620
| -2% | -$404K | 0.25% | 76 |
|
|
2019
Q3 | $13.1M | Buy |
840,430
+331,589
| +65% | +$5.15M | 0.23% | 83 |
|
|
2019
Q2 | $10.3M | Buy |
+508,841
| New | +$10.3M | 0.2% | 86 |
|